Below companies have either been created by Forty51 Ventures or received their first financing from Forty51 Ventures as lead, or co-lead investor, in its first institutional financing.
Neuroscience Company in Stealth Mode
Neurodegenerative Diseases Associated with Immune Dysfunction
Allegria Therapeutics, Basel
Acute and Chronic Mast-Cell Driven Diseases
Melodia Therapeutics, Basel